Table 1. Anthropometrics and clinical characteristics of Chronic Heart Failure (CHF) subjects.
| CHF (n=7) | |
|---|---|
| Age (years) | 62±8 |
| Height (m) | 1.66±0.07 |
| Mass (kg) | 68.06±9.84 |
| Body mass index (kg/m²) | 24.67±3.73 |
| Echocardiography | |
| Left ventricle ejection fraction (%) | 41±8 |
| Etiology of CHF | |
| Ischemic | 4 |
| Nonischemic | 3 |
| NYHA class | |
| II/III | 4/3 |
| Spirometrics | |
| FEV1 (% predict) | 80.29±8.58 |
| FEV1/FVC (%) | 82.00±4.24 |
| Clinical characteristics | |
| SpO2 (%) | 96±2 |
| RF (ipm) | 14±4 |
| Drugs | |
| Diuretics | 3 |
| Digitalis | 5 |
| b – blocker | 7 |
| Angiotensin-converting enzyme inhibitor | 6 |
| Incremental test | |
| At rest | |
| SAP (mmHg) | 110±10 |
| DAP (mmHg) | 75±9 |
| HR (bpm) | 67±9 |
| Peak | |
| SAP (mmHg) | 141±18 |
| DAP (mmHg) | 80±10 |
| HR (bpm) | 100±20 |
| Power (watts) | 36±9 |
Values are means ± SD
FEV1
: forced expiratory volume in the first second
FEV1/FVC
: forced expiratory volume in the first second and forced vital capacity ratio
SpO2
: peripheral oxygen saturation
RF
: respiratory frequency
SAP
: systolic arterial pressure
DAP
: diastolic arterial pressure
HR
: heart rate
NYHA
: New York Heart Association